In conclusion, CHI3L1 serves as a key molecule linking epithelial inflammation to macrophage polarization, and its mechanism of regulating the immune microenvironment through the STAT3/NF-κB pathway provides a novel therapeutic target for colitis. The gene discussed is STAT3; the disease is colitis.